Refreshing results…
Venetoclax and Ibrutinib for Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia
UploadCOVID-19 among fit patients with CLL treated with venetoclax-based combinations
UploadMachine learning can identify newly diagnosed patients with CLL at high risk of infection
Download from www.nature.comTargeting Bruton’s Tyrosine Kinase Across B-Cell Malignancies
Download from link.springer.comSoluble CD52 is an indicator of disease activity in chronic lymphocytic leukemia
UploadMissing publications? Search for publications with a matching author name.